Optimizing long-term joint health in the treatment of hemophilia-Reference-Cited by-同舟云学术

Optimizing long-term joint health in the treatment of hemophilia

Published:2024-09-08 Issue: Volume: Page:1-10
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Gualtierotti Roberta¹²,Giachi Andrea²,Suffritti Chiara¹,Bedogni Luca³,Franco Francesco³,Poggi Francesco⁴,Mascetti Sergio⁵,Colussi Marco⁵,Ahmetovic Dragan⁵,Begnozzi Valentina¹,Boccalandro Elena Anna¹,Solimeno Luigi Piero⁶,Peyvandi Flora¹²

Affiliation:

1. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

2. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

3. Dipartimento di Scienze Fisiche, Informatiche e Matematiche, Università degli Studi di Modena e Reggio Emilia, Modena, Italy

4. Institute for Cognitive Sciences and Technologies (ISTC), National Research Council (CNR), Bologna, Italy

5. Department of Computer Science, Università degli Studi di Milano, Milan, Italy

6. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Division of Orthopaedic Surgery and Traumatology, Milan, Italy

Funder

Ministry of Health – Bando Ricerca Corrente

Italian Ministry of University and Research

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2024.2396617

Reference86 articles.

1. Hemophilic arthropathy: Current knowledge and future perspectives

2. Hemophilia treatment innovation: 50 years of progress and more to come

3. Franchini M Mannucci PM. The more recent history of hemophilia treatment. Seminars thrombosis hemostasis. 2022;48(8):904–910. doi: 10.1055/s-0042-1756188

4. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

5. Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies